This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A stock index measures the performance of a defined group of stocks, reflecting overall market or segment trends for comparison.
20,961 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
A prominent hedge fund just sold its entire XPeng stake, triggering questions for everyday investors. Learn how to ev...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
A top analyst’s optimistic view on Micron highlights AI-driven memory demand and a potential upcycle in DRAM and NAND...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...
Nvidia still dominates AI hardware, but the stock's sparkle has cooled. This article breaks down the three big reason...
As spacex insider lockups start, investors watch for how staged unlocks could affect liquidity and volatility. This a...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
AMD has delivered a staggering run, rising nearly 300% over past year. This article breaks down whether the momentum ...